Well as you say we all have our opinions .. It may do as you say but imo if it does it will be fleeting . If positive news comes out on the FDA and Nasdaq listing as I expect it will be then IMO it will rerate significantly .
We then also have the other trials and psychedelics to come so I am of the view that it is a matter of time and gap fill or not it will be a blip . If they announce positive news before any potential gap fill ( and that the gap fill is not assured ) then imo the gap will not fill as it will breakaway on a significant rerate imo .
CHART Thread, page-247
-
- There are more pages in this discussion • 2,759 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)